Updated April 2024

Our past work for opioid manufacturers, while lawful, fell short of the high standards we set for ourselves. We apologized for this past work and were the first company to work with U.S. State Attorneys General to help communities affected by the crisis. We have also reached agreements with political subdivisions, school districts, Native American tribes and third-party payors. The firm entered into these agreements, which contain no admissions of liability or wrongdoing, to avoid the time and expense of protracted litigation and support efforts to help those affected by the opioid epidemic.

In 2019, McKinsey committed to no longer advise clients on any opioid-related business anywhere in the world. More broadly, we have implemented a rigorous client selection policy and invested more than $700 million since 2018 to strengthen our risk management teams, capabilities, and processes.